Medtronic: The Investment Appeal of a Medical Device Giant
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 21 2026
0mins
Source: Fool
- Diversified Business Portfolio: Medtronic, as one of the world's largest medical device companies, operates across cardiovascular, neuroscience, and surgical sectors, and despite the upcoming spinoff of its diabetes business, it maintains strong growth potential, showcasing its competitive edge in the healthcare market.
- Innovation-Driven Growth: The Hugo surgical robot exemplifies Medtronic's innovative capabilities in a rapidly growing medical market, and with a long history of success, the company's ongoing investments at the technological forefront keep it ahead in the industry.
- Stable Dividend Record: With 48 consecutive years of dividend increases, Medtronic is nearing the status of a 'Dividend King', and this robust dividend growth record reflects its solid business model and execution during economic fluctuations, enhancing investor confidence.
- Future Growth Expectations: The company anticipates a revenue growth of 5.5% for fiscal 2026, and in the context of a $120 billion market value, this target indicates that Medtronic is beginning to see early benefits from its transformation, further solidifying its market position.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy MDT?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on MDT
Wall Street analysts forecast MDT stock price to rise
20 Analyst Rating
11 Buy
9 Hold
0 Sell
Moderate Buy
Current: 75.570
Low
102.00
Averages
111.76
High
120.00
Current: 75.570
Low
102.00
Averages
111.76
High
120.00
About MDT
Medtronic Public Limited Company is an Ireland-based company, which provides healthcare technology solutions. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Earnings Reports and Tech Conferences This Week
- Earnings Reports: This week, Palo Alto Networks, CrowdStrike, and Broadcom are set to report earnings, with Palo Alto expected to post $0.80 per share on $2.94 billion in revenue, while CrowdStrike is projected to report $1.07 per share on $1.36 billion, highlighting strong market interest in cybersecurity.
- AI-Driven Market Rebound: As AI technology becomes more prevalent, both Palo Alto and CrowdStrike have seen their stock prices rebound to all-time highs, and despite facing high valuation pressures, market expectations for their future performance remain optimistic, making management's outlook a key focus for investors.
- Tech Conference Highlights: Nvidia, Arm, and Microsoft will discuss AI-related topics at tech conferences this week, with Nvidia CEO Jensen Huang scheduled to deliver a keynote on Monday, where he is expected to unveil a new product, potentially personal computers powered by its GPUs, further boosting its market share.
- Labor Market Data: The JOLTS report will be released this week, with expectations of 120,000 new private sector jobs added in May and an unemployment rate holding steady at 4.3%, reflecting economic resilience, and investors will closely monitor these figures for their potential impact on inflation and monetary policy.
See More
Preparing for Economic Recession: Resilient Stock Picks
- Consumer Resilience: Coca-Cola and Procter & Gamble, both Dividend Kings, maintain high dividend yields of 2.6% and 2.9% respectively, showcasing their robust business models and market adaptability, which help stabilize cash flow during economic downturns.
- Healthcare Sector Stability: Johnson & Johnson and Medtronic also demonstrate strong performance in the healthcare sector, offering dividend yields of 2.3% and 3.6%, indicating that the inelastic demand for medical care allows these companies to remain profitable amid economic fluctuations.
- Valuation Insights: Coca-Cola's price-to-earnings ratio is slightly below its five-year average, suggesting reasonable pricing, while Procter & Gamble's P/E is even lower, indicating potential undervaluation that may attract value investors.
- Portfolio Strategy: Given the increasing risk of economic recession, investors are advised to consider adding these resilient consumer and healthcare stocks to their portfolios to mitigate potential economic downturn risks.
See More
Resilient Stocks to Consider Amid Recession Fears
- Resilient Sector Focus: In light of impending economic recessions, investors are advised to concentrate on resilient sectors such as consumer staples and healthcare, which maintain stable cash flows and profitability by selling essential everyday products even during downturns.
- Coca-Cola and Procter & Gamble: Both companies, recognized as 'Dividend Kings', offer dividend yields of 2.6% and 2.9% respectively, with their price-to-earnings ratios currently below their five-year averages, indicating that their stock prices are reasonably valued and suitable for income-seeking investors.
- Strong Healthcare Options: Johnson & Johnson and Medtronic also demonstrate resilience in the healthcare sector, with dividend yields of 2.3% and 3.6% respectively; while J&J's P/E is above its five-year average, its diversified operations provide investors with effective risk management.
- Medtronic's Growth Potential: Medtronic achieved its highest revenue growth rate in ten quarters during Q3 of fiscal 2026, and although the company is undergoing restructuring to enhance innovation, its attractive dividend yield compensates investors for their patience during this transition.
See More
Dell Technologies Poised to Dominate Computer Market
- Dell's Impressive Earnings: Dell Technologies' latest earnings report is described as a 'blowout,' indicating strong market demand that could signify its dominance in the computer space, further fueling enthusiasm around data center trades.
- Nvidia's Challenges: While tech stocks have performed well, Nvidia has emerged as a notable laggard, with expectations that CEO Jensen Huang's upcoming keynote at Computex in Taiwan could introduce new products and potentially shift this trend.
- Market Dynamics to Watch: Next week, Merck will review its cancer portfolio, while Palo Alto Networks and Ulta are set to report earnings; Cramer anticipates that these companies may be influenced by AI-driven market changes, particularly in cybersecurity.
- Employment Data Impact: The Labor Department's jobs report on Friday will shape expectations for interest rate cuts, with Cramer noting that the data needs to be weak enough to justify a rate cut from the Federal Reserve, which could influence investor decisions.
See More
Dell Technologies Earnings Ignite AI Enthusiasm
- Dell's Blockbuster Earnings: Dell Technologies' recent earnings report is described as a 'blowout,' reigniting enthusiasm for AI and data center stocks, and potentially marking a pivotal moment for its dominance in the computer space.
- Nvidia's Lagging Performance: Despite the strong performance of tech stocks, Nvidia has emerged as a laggard, with Cramer suggesting that next week's Computex keynote by CEO Jensen Huang could provide crucial updates that may shift this trend.
- Upcoming Earnings Reports: A series of earnings reports from companies like Palo Alto and Broadcom next week are expected to offer significant insights for investors, particularly regarding the rising AI-driven cybersecurity threats that could impact results.
- Lululemon's Reset Quarter: Cramer cautions that Lululemon may face a challenging 'reset quarter,' advising investors to be cautious ahead of the earnings report to mitigate potential losses.
See More
Trane Technologies Market Cap Reaches $99.97 Billion
- Market Cap Comparison: Trane Technologies (TT) boasts a market cap of $99.97 billion compared to Medtronic (MDT) at $97.02 billion, indicating a competitive edge that may attract more attention from large funds.
- Investor Misconceptions: Many novice investors mistakenly compare stock prices to gauge company value, yet market capitalization provides a more accurate assessment, enabling smarter investment decisions.
- Market Positioning Impact: A company's market cap not only affects its ranking among peers but also determines which mutual funds and ETFs may invest in the stock, influencing its liquidity and market performance.
- Stock Price Fluctuations: At Friday's close, TT's stock fell approximately 0.1%, while MDT's dropped about 2.4%, reflecting differing market sentiments and expectations for the two companies.
See More
Earnings Reports and Tech Conferences This Week
- Earnings Reports: This week, Palo Alto Networks, CrowdStrike, and Broadcom are set to report earnings, with Palo Alto expected to post $0.80 per share on $2.94 billion in revenue, while CrowdStrike is projected to report $1.07 per share on $1.36 billion, highlighting strong market interest in cybersecurity.
- AI-Driven Market Rebound: As AI technology becomes more prevalent, both Palo Alto and CrowdStrike have seen their stock prices rebound to all-time highs, and despite facing high valuation pressures, market expectations for their future performance remain optimistic, making management's outlook a key focus for investors.
- Tech Conference Highlights: Nvidia, Arm, and Microsoft will discuss AI-related topics at tech conferences this week, with Nvidia CEO Jensen Huang scheduled to deliver a keynote on Monday, where he is expected to unveil a new product, potentially personal computers powered by its GPUs, further boosting its market share.
- Labor Market Data: The JOLTS report will be released this week, with expectations of 120,000 new private sector jobs added in May and an unemployment rate holding steady at 4.3%, reflecting economic resilience, and investors will closely monitor these figures for their potential impact on inflation and monetary policy.
See More
Preparing for Economic Recession: Resilient Stock Picks
- Consumer Resilience: Coca-Cola and Procter & Gamble, both Dividend Kings, maintain high dividend yields of 2.6% and 2.9% respectively, showcasing their robust business models and market adaptability, which help stabilize cash flow during economic downturns.
- Healthcare Sector Stability: Johnson & Johnson and Medtronic also demonstrate strong performance in the healthcare sector, offering dividend yields of 2.3% and 3.6%, indicating that the inelastic demand for medical care allows these companies to remain profitable amid economic fluctuations.
- Valuation Insights: Coca-Cola's price-to-earnings ratio is slightly below its five-year average, suggesting reasonable pricing, while Procter & Gamble's P/E is even lower, indicating potential undervaluation that may attract value investors.
- Portfolio Strategy: Given the increasing risk of economic recession, investors are advised to consider adding these resilient consumer and healthcare stocks to their portfolios to mitigate potential economic downturn risks.
See More
Resilient Stocks to Consider Amid Recession Fears
- Resilient Sector Focus: In light of impending economic recessions, investors are advised to concentrate on resilient sectors such as consumer staples and healthcare, which maintain stable cash flows and profitability by selling essential everyday products even during downturns.
- Coca-Cola and Procter & Gamble: Both companies, recognized as 'Dividend Kings', offer dividend yields of 2.6% and 2.9% respectively, with their price-to-earnings ratios currently below their five-year averages, indicating that their stock prices are reasonably valued and suitable for income-seeking investors.
- Strong Healthcare Options: Johnson & Johnson and Medtronic also demonstrate resilience in the healthcare sector, with dividend yields of 2.3% and 3.6% respectively; while J&J's P/E is above its five-year average, its diversified operations provide investors with effective risk management.
- Medtronic's Growth Potential: Medtronic achieved its highest revenue growth rate in ten quarters during Q3 of fiscal 2026, and although the company is undergoing restructuring to enhance innovation, its attractive dividend yield compensates investors for their patience during this transition.
See More
Dell Technologies Poised to Dominate Computer Market
- Dell's Impressive Earnings: Dell Technologies' latest earnings report is described as a 'blowout,' indicating strong market demand that could signify its dominance in the computer space, further fueling enthusiasm around data center trades.
- Nvidia's Challenges: While tech stocks have performed well, Nvidia has emerged as a notable laggard, with expectations that CEO Jensen Huang's upcoming keynote at Computex in Taiwan could introduce new products and potentially shift this trend.
- Market Dynamics to Watch: Next week, Merck will review its cancer portfolio, while Palo Alto Networks and Ulta are set to report earnings; Cramer anticipates that these companies may be influenced by AI-driven market changes, particularly in cybersecurity.
- Employment Data Impact: The Labor Department's jobs report on Friday will shape expectations for interest rate cuts, with Cramer noting that the data needs to be weak enough to justify a rate cut from the Federal Reserve, which could influence investor decisions.
See More
Dell Technologies Earnings Ignite AI Enthusiasm
- Dell's Blockbuster Earnings: Dell Technologies' recent earnings report is described as a 'blowout,' reigniting enthusiasm for AI and data center stocks, and potentially marking a pivotal moment for its dominance in the computer space.
- Nvidia's Lagging Performance: Despite the strong performance of tech stocks, Nvidia has emerged as a laggard, with Cramer suggesting that next week's Computex keynote by CEO Jensen Huang could provide crucial updates that may shift this trend.
- Upcoming Earnings Reports: A series of earnings reports from companies like Palo Alto and Broadcom next week are expected to offer significant insights for investors, particularly regarding the rising AI-driven cybersecurity threats that could impact results.
- Lululemon's Reset Quarter: Cramer cautions that Lululemon may face a challenging 'reset quarter,' advising investors to be cautious ahead of the earnings report to mitigate potential losses.
See More
Trane Technologies Market Cap Reaches $99.97 Billion
- Market Cap Comparison: Trane Technologies (TT) boasts a market cap of $99.97 billion compared to Medtronic (MDT) at $97.02 billion, indicating a competitive edge that may attract more attention from large funds.
- Investor Misconceptions: Many novice investors mistakenly compare stock prices to gauge company value, yet market capitalization provides a more accurate assessment, enabling smarter investment decisions.
- Market Positioning Impact: A company's market cap not only affects its ranking among peers but also determines which mutual funds and ETFs may invest in the stock, influencing its liquidity and market performance.
- Stock Price Fluctuations: At Friday's close, TT's stock fell approximately 0.1%, while MDT's dropped about 2.4%, reflecting differing market sentiments and expectations for the two companies.
See More
